Research Progress of Cerebral Proliferative Angiopathy

doi:10.3969/j.issn.1673-5765.2017.06.016

Abstract

Abstract:

Cerebral proliferative angiopathy (CPA) is a chronic ischemic cerebrovascular disease for unknown reason. CPA is demonstrated as a diffuse network of densely enhancing vascular spaces and have angiographic hallmarks of diffuse proliferated vascular blood supply. It takes the share of 3.4% in arteriovenous malformations, but its clinical manifestations and prognosis are significantly different from the arteriovenous malformations. CPA is usually manifested with epilepsy, headache and progressive neurological deficits. Since CPA is just raised as independent issue in recent years, there are no domestic literature before April 6, 2016. This paper is to review recent studies based on the pathology, clinical manifestations, and imaging characteristics aiming at raising awareness of the CPA so as to pave the way for better diagnosis and treatment in the near future.

Key words: Proliferation of cerebrovascular disease; Epidemiology; Clinical characteristics; Imaging features

摘要：

增殖性脑血管病（cerebral proliferative angiopathy，CPA）是一种原因不明的慢性缺血性脑血管疾病，是以颅内存在弥漫性密集增强的巨大血管网状空间，同时具有弥漫的增生血管供血为影像学特征表现的脑血管病。其在颅内动静脉畸形中占3.4%的比重，但临床表现及预后与动静脉畸形明显不同。其表现主要为癫痫、头痛和进行性神经功能缺损。由于该疾病直到近几年才被单独提出来，截至2016年4月6日，国内尚无文献对其报道。本文就CPA的病理、临床表现、影像学特点等最新研究做综述，旨在提高对CPA的认识，为未来更好地诊治做铺垫。

关键词: 增殖性脑血管病; 流行病学; 临床特点; 影像学特征

YUAN Zheng-Zhou, ZHENG Hong-Bo,LI Jing-Lun, et al.. Research Progress of Cerebral Proliferative Angiopathy[J]. Chinese Journal of Stroke, 2017, 12(06): 550-553.

袁正洲，郑洪波，李经伦，李作孝. 增殖性脑血管病研究进展[J]. 中国卒中杂志, 2017, 12(06): 550-553.

References

1 Ducreux D，Petit-Lacour MC，Marsot-Dupuch K，

et al. MR perfusion imaging in a case of cerebral

proliferative angiopathy[J]. Eur Radiol，2002，12：

2717-2722.

2 Lasjaunias PL，Landrieu P，Rodesch G，et al.

Cerebral proliferative angiopathy：clinical and

angiographic description of an entity different from

cerebral AVMs[J]. Stroke，2008，39：878-885.

3 Chin LS，Raffel C，Gonzalez-Gomez I，et al. Diffuse

arteriovenous malformations：a clinical，radiological，

and pathological description[J]. Neurosurgery，1992，

31：863-868；discussion 868-869.

4 Kumar S，Sharma M，Srivastava T，et al.

Infratentorial hemorrhagic cerebral proliferative

angiopathy：A rare presentation of a rare disease[J].

Asian J Neurosurg，2015，10：240-242.

5 Fierstra J，Spieth S，Tran L，et al. Severely impaired

cerebrovascular reserve in patients with cerebral

proliferative angiopathy[J]. J Neurosurg Pediatr，2011，

8：310-315.

6 Kumar S，Srivastava T，Tejwani S，et al. Cerebral

proliferative angiopathy with papilledema[J]. Clin

Neurol Neurosurg，2015，139：12-15.

7 Hong KS，Lee JI，Hong SC. Neurological picture.

Cerebral proliferative angiopathy associated with

haemangioma of the face and tongue[J]. J Neurol

Neurosurg Psychiatry，2010，81：36-37.

8 Khwaja GA，Bohra V，Duggal A，et al. Cerebral

proliferative angiopathy：Rare case of seizures，bone

erosion，and pulsatile head bump[J]. Neurology，2015，

84：2462-2463.

9 Vargas MC，Castillo M. Magnetic resonance

perfusion imaging in proliferative cerebral

angiopathy[J]. J Comput Assist Tomogr，2011，35：33-

38.

10 Dória-Netto HL，Souza-Filho AM，Dória-Netto

RH，et al. Cerebral proliferative angiopathy[J]. Arq

Neuropsiquiatr，2010，68：300-302.

11 Eesa M，Sharma P，Goyal M. Cerebral proliferative

angiopathy[J]. Can J Neurol Sci，2009，36：242-243；

discussion 135.

12 Khan A，Rattihalli R，Beri S，et al. Cerebral

proliferative angiopathy：a rare form of vascular

malformation[J]. J Paediatr Child Health，2013，49：

504-505.

13 Srivastava T，Mathur T，Jain R，et al. Cerebral

proliferative angiopathy：A rare clinical entity with

peculiar angiographic features[J]. Ann Indian Acad

Neurol，2013，16：674-675.

14 Kono K，Terada T. Encephaloduroarteriosynangiosis

for cerebral proliferative angiopathy with cerebral

ischemia[J]. J Neurosurg，2014，121：1411-1415.

15 Rohit，Goh PS. Diffuse Proliferative Cerebral

Angiopathy：A case report and review of the

literature[J]. J Radiol Case Rep，2015，9：1-10.

[1]	CHENG Shi, LI Jing, GUO Junping, HU Aixiang, YU Xinwei, HAN Wei, LIANG Ying, ZHANG Yuewei, JI Ruijun. Clinical Characteristics and Risk Factors of Infection in Patients with Acute Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(10): 1065-1070.
[2]	FU Heguan, SHEN Xuxuan, XU Jiali, ZHANG Houdi, LI Bin, ZOU Zhengxing, FENG Jie, DUAN Lian, HAN Cong. The Types and Risk Factors of Stroke in Young Patients with Moyamoya Disease [J]. Chinese Journal of Stroke, 2022, 17(09): 937-943.
[3]	LIAO Qiuju, ZHAO Yi, LI Xia. Clinical Characteristics of Parenchymal Neuro-Behçet Syndrome [J]. Chinese Journal of Stroke, 2021, 16(12): 1204-1209.
[4]	LU Qing-Li, WANG Jing, LIU Zhong-Zhong, LIU Pei, LIU Yan, CHANG Qiao-Qiao, LIN Xue-Mei, SHI Ya-Ling, WANG Fang, WU Song-Di. Clinical Characteristics and 1-Year Prognosis of First-ever Cerebral Infarction Patients with Atrial Fibrillation in Xi'an [J]. Chinese Journal of Stroke, 2021, 16(11): 1131-1136.
[5]	GAO Yu, FENG Xue-Dan, WANG Xiang-Bo, YAN He-Li, MA Hong-Mei, ZOU Can. Clinical Characteristics of 25 Cases Series with Spinal Dural Arteriovenous Fistula [J]. Chinese Journal of Stroke, 2021, 16(11): 1137-1143.
[6]	LU Qing-Li, LIU Zhong-Zhong, LIU Pei, CHANG Qiao-Qiao, LIU Yan, WANG Jing, LIN Xue-Mei, WANG Fang, SHI Ya-Ling, WU Song-Di. Clinical Characteristics and 1-Year Prognosis of Patients with Acute Recurrent Cerebral Infarction in Xi’an [J]. Chinese Journal of Stroke, 2021, 16(08): 787-792.
[7]	ZHAO Shang-Feng, WANG Wei, LIANG Xi-Hong, ZHANG Jia-Liang, SUN Si, SONG Gui-Dong, KANG Jun. Endovascular Therapy for Spontaneous Cavernous Sinus Dural Arteriovenous Fistula [J]. Chinese Journal of Stroke, 2021, 16(08): 828-833.
[8]	HU Jun-Xian, HU Yue-Yun, LI Xiao-Hua, XIONG Gang, LI Hai-Tao, LIU Chang-Ya, XIONG Zhi-Yong, HU Xue-Bin. Clinical Characteristics and Treatment of Patients with Coronavirus Disease 2019 and Hemorrhagic Cerebrovascular#br# Disease#br# [J]. Chinese Journal of Stroke, 2021, 16(07): 670-674.
[9]	GUO Shan-Shan, CHEN Hong-Xia, WU Yi-Ping, LIN Jie. Progress of Vascular Parkinsonism [J]. Chinese Journal of Stroke, 2018, 13(09): 990-994.
[10]	ZHOU Meng-Yuan, CHEN Wei-Qi, JING Jing, WANG Yong-Jun, WANG Yi-Long. Epidemiology and Prognosis of Non-Disabling Ischemic Cerebrovascular Events [J]. Chinese Journal of Stroke, 2018, 13(05): 473-476.
[11]	FANG Ya-Lan, CHANG Jun-Sen, NIU Xiao-Yuan. Cervical Artery Dissection: Imaging Feature and Prognostic Analysis [J]. Chinese Journal of Stroke, 2018, 13(03): 232-236.
[12]	CHEN Hong-Xia,GUO Shan-Shan, WU Yi-Ping, SONG Yan-Li, LIN Jie. The Research Progress of Vascular Cognitive Impairment-no Dementia [J]. Chinese Journal of Stroke, 2017, 12(12): 1148-1153.
[13]	TAO Wen, KE Kai-Fu. Research Progress of Cerebral Small Vessel Disease [J]. Chinese Journal of Stroke, 2017, 12(02): 147-151.
[14]	CHEN Lei, ZHU Xuan, ZHANG Ping, et al.. The Analysis of Clinical Characteristics and Cause of Magnetic Resonance Imaging Diffusion-weighted Imaging Negative Stroke [J]. Chinese Journal of Stroke, 2017, 12(01): 29-33.
[15]	LYU Xiao-Yu,JU Yi, ZHAO Xing-Quan. Clinical Characteristics and Outcome of Benign Paroxysmal Positional Vertigo [J]. Chinese Journal of Stroke, 2016, 11(12): 1023-1029.